1 | RCB2202 293T | Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14 | Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry |
2 | RCB0007 HeLa | Bioorg Med Chem Lett. 2017 Jun 15;27(12):2746-2751 | Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor |
3 | RCB0995 MDCK | Clin Infect Dis. 2020 Oct 3;ciaa1517 | Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19 |
4 | RCB0535 RAW 264 | Viruses. 2020 Jun 28;12(7):699 | Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2 |
5 | RCB0988 CACO-2
CSII-CMV-MCS-IRES2-Bsd | PLoS Pathog. 2021 Jan 21;17(1):e1009233. | SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells |
6 | RCB0485 LA-N-5 | Sci Rep. 2021 Feb 9;11(1):3379 | Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19 |
7 | RCB2202 293T | Cell. 2021 Jun 24;184(13):3452-3466.e18 | An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies |
8 | RCB1902 HSC-4 | J Anat. 2021 Jun;238(6):1341-1354 | Expression of SARS‐CoV‐2 entry factors in human oral tissue |
9 | RCB0209 SP2/0-Ag14 | J Biol Chem. Jan-Jun 2021;296:100346 | Potent mouse monoclonal antibodies that block SARS-CoV-2 infection |
10 | RCB0988 CACO-2
RCB2202 293T | Sci Rep. 2021 Mar 8;11(1):5376 | MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2 |
11 | RCB0988 CACO-2 | J Virol. 2022 Mar 23;96(6):e0000222
(bioRxiv. June 30, 2021) | Host cellular RNA helicases regulate SARS-CoV-2 infection |
12 | RCB0211 MRC-5 | Cell Rep Med. 2021 Jun 15;2(6):100311 | Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests |
13 | RCB2202 293T | bioRxiv. August 23, 2021 | The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines |
14 | RCB0098 A549 | Biochemical and Biophysical Research Communications.77, 5 November 2021, Pages 146-151 | Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
15 | HPS0002 253G1 | J Toxicol Sci. 2021; 46(9):425-435 | Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing |
16 | RCB0098 A549
RCB0988 CACO-2
RCB1942 HuH-7 | iScience. 2021 Oct 22;24(10):103120 | 5-Hydroxymethyltubercidin exhibits potent antiviral activity against flaviviruses and coronaviruses, including SARS-CoV-2 |
17 | RCB0771 XTC-YF | Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):477-484 | Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile |
18 | RCB1168 SKW-3 | Commun Biol. 2021 Dec 2;4(1):1365 | Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2 |
19 | RCB0001 Vero | iScience. 2021 Nov 17;103379 | Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2 |
20 | RCB0098 A549
RCB0988 CACO-2
HuH-7 | Nat Commun. 2021 Nov 15;12(1):6602 | SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis |
21 | RCB4557 HUDEP-2 | Nat Genet. 2021 Nov;53(11):1606-1615 | Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus |
22 | RCB0995 MDCK | J Infect Chemother. 2022 Feb;28(2):252-256. | Stability of SARS-CoV-2 and influenza virus varies across different paper types |
23 | RCB0988 CAC0-2 | Experimental and Therapeutic Medicine 2022-2-10 | Indigo plant leaf extract inhibits the binding of SARS‑CoV‑2 spike protein to angiotensin‑converting enzyme 2
|
24 | NIH3T3 | Cancer Sci. 2022 Aug;113(8):2536-2547 | A single immunization with cellular vaccine confers dual protection against SARS-CoV-2 and cancer |
25 | RCB2202 293T | J Med Chem. 2022 Oct 27;65(20):13852-13865 | Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease |
26 | RCB2202 293T
RCB0001 Vero | Pharm Res. 2022 Sep 26;1-9 | Preventing SARS-CoV-2 Infection Using Anti-spike Nanobody-IFN-β Conjugated Exosomes |
27 | RCB1637 293 | Commun Biol. 2022 Nov 5;5(1):1188 | ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner |
28 | RCB2630 B16F10 | Cell. 2022 Jun 9;185(12):2103-2115.e19 | Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike |
29 | RCB0098 A549
RCB2202 293T | J Biol Chem. 2022 Nov;298(11):102500 | Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis |
30 | RCB0995 MDCK
RCB2202 293T | J Nat Prod. 2022 Nov 25;85(11):2583-2591 | Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant Streptomyces sp. JA74, Exhibiting Antiviral Activity against Influenza and SARS-CoV-2 Viruses |
31 | RC2202 293T | Sci Transl Med. 2023 Jan 18;15(679):eabq4064 | S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters |
32 | RC2202 293T
RCB0001 Vero | iScience. 2023 Jan 20;26(1):105742 | Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists |